Central Rater Committees
Design and implementation of adjudication committees, central review panels, independent endpoint committees, and clinical event committees. The infrastructure that ensures your endpoint data is unbiased, consistent, and defensible.
In CNS clinical trials, the quality of endpoint data depends as much on how assessments are administered and adjudicated as on which assessments are chosen. Rater variability, site-level drift, and inconsistent application of scoring criteria can introduce noise that obscures real treatment signals and creates vulnerabilities in regulatory review.
Central rater committees provide the organizational infrastructure to control these risks. By establishing standardized training, calibration procedures, and ongoing quality monitoring, a well-designed central rater program ensures that every data point collected across every site meets the same standard of rigor.
We design and implement these committee structures from the ground up, tailored to your trial's specific endpoint portfolio, site network, and regulatory requirements. Whether you need a full adjudication committee for a primary endpoint, a central review panel for safety event classification, or a rater training and qualification program, we build the system, train the people, and monitor the quality throughout the trial.
What We Deliver
Committee Architecture Design
Design the complete organizational structure: committee composition, decision rules, escalation pathways, and integration with your clinical operations team.
Rater Training & Qualification
Develop standardized training curricula, qualification assessments, and ongoing calibration procedures that maintain scoring consistency across all sites.
Quality Monitoring Programs
Implement real-time surveillance of scoring patterns, inter-rater reliability tracking, and drift detection systems that flag issues before they compromise data integrity.
Adjudication Workflows
Build blinded adjudication processes for endpoint events, including case preparation protocols, voting procedures, and documentation requirements.
Bias Mitigation
Design structural safeguards against common sources of bias in clinical endpoint assessment: expectation bias, halo effects, central tendency, and site-level scoring drift.
Regulatory Documentation
Produce all committee charters, operating procedures, and quality reports in formats aligned with FDA inspection expectations and submission requirements.
Typical Deliverables
Ensure your endpoint data is unassailable
Talk to us about designing a central rater program that protects the integrity of your clinical trial data from first patient in through regulatory submission.
Start the Conversation